Patients Discuss and Debate the Medical Outcomes from Generic Formulations
Patients Discuss and Debate the Medical Outcomes from Generic Formulations By Jeff Terkowitz When mature products face the introduction of generics, patients are often considering, or asked to consider, switching their medications. [...]
HEOR: Incorporating the Human Costs and Benefits into Drug Value
HEOR: Incorporating the Human Costs and Benefits into Drug Value By Kathleen Hoffman, PhD, MSPH In a 2007 article, “Pinning Down the Money Value of a Person’s Life,” NY Times reporter Alex [...]
The Bladder Cancer Advocacy Network Support Community on Inspire Talks about Treatments
The Bladder Cancer Advocacy Network Support Community on Inspire Talks about Treatments By Kathleen Hoffman, PhD, MSPH If asked to list the most common cancers in the U.S., most people would include [...]
FDA Finalizes First of Four PFDD Industry Guidances
FDA Finalizes First of Four PFDD Industry Guidances By Marina Ness, MA On June 16th, the FDA released the final version of “Patient-Focused Drug Development: Collecting Comprehensive and Representative Input.” This document, [...]
How has the COVID-19 Pandemic Impacted Chronically Ill Patients? Patient Reported Outcomes
How has the COVID-19 Pandemic Impacted Chronically Ill Patients? Patient Reported Outcomes By Kathleen Hoffman, PhD, MSPH Research in health and medicine has largely used quantitative methods. Using mixed methods, combining qualitative [...]
Treatment Discussions of Rheumatoid Arthritis on Inspire
Treatment Discussions of Rheumatoid Arthritis on Inspire By Kathleen Hoffman, PhD, MSPH When someone says “arthritis,” do you imagine an elderly person? When joints deteriorate through age and use, that’s osteoarthritis. But [...]
Bringing Patients and the Life Science Industry Together: Patient Advocacy +
Bringing patients and the life science industry together: Patient Advocacy + By Robert Schultz “Progress is personal,” according to Bob Coughlin, President and CEO of the Massachusetts Biotechnology Council (MassBio) and the [...]
Why Limit Awareness Trial Usage Surveys (ATUs) to HCPs? Patients and Caregivers Provide Needed Insights
Why Limit Awareness Trial Usage Surveys (ATUs) to HCPs? Patients and Caregivers Provide Needed Insights By Richard Tsai One online glossary defining ATUs (Awareness, Trial, and Usage studies) described them, in [...]
Patients Enroll In Studies When They Have a Voice: Real World Study Succeeds with Patient Voice
Patients Enroll In Studies When They Have a Voice: Real World Study Succeeds with Patient Voice By Kathleen Hoffman, PhD, MSPH The most persistent hurdle in running a clinical trial is [...]
Patient Support Needs Patient Input
Patient Support Needs Patient Input By Jeff Terkowitz Here’s a patient support marketing scenario: You’re in charge of creating a patient support program that reaches out past the point of prescription. The [...]